Astellas Pharma Inc. is a Japanese pharmaceutical company which aims to become an R&D-driven global pharmaceutical company contributing to people's health. The Astellas Group’s business philosophy has three elements — raison d'être, mission and beliefs. This business philosophy expresses the company’s of aiming to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals, while continuously increasing the Company's enterprise value.
Creating new drugs and supplying them to the patients who need them takes many years and involves many different stages and processes. The first stage is that of research, in which the most promising candidate for the discovery of a new drug must be found from among a huge number of compounds. Next comes the development stage, centering on the conduct of clinical trials, followed by mass-production. Finally, the drugs are made available to the front line of medical treatment, together with the necessary information on their appropriate use. From that point on the pharmaceutical maker also acquires a steady stream of feedback from medical workers, which enables the further refinement of the drugs. This is the responsibility of Medical Representatives (MRs). At Astellas Pharma, each stage in this long chain of processes is handled by teams of specialists who possess high-level expertise.
Global Research Network: strengthening drug discovery capabilities and accelerating exploratory research
To deliver a new drug to patients as soon as possible, Astellas Pharma are centering drug creation efforts in the five strategic focus therapeutic fields of urology, immunology and infectious diseases, oncology, neuroscience, and DM complications and metabolic diseases.
Development: targeting safe, effective drugs
Candidate compounds for new drugs found during the drug discovery research process are subjected to detailed examination to confirm their safety and efficacy - the two qualities that are of paramount importance.
Manufacturing & Technology: working to maintain leading-drug status
Once a drug has been approved for use, it is the role of the staff at production plants, and of the technological development units that support those plants, to ensure the smooth realization of mass-production. At Astellas, Astellas Pharma have drawn up the own standards of good manufacturing practice (GMP), which meet globally accepted quality standards.
Where is Astellas Pharma